Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

Monticone S, Hattangady NG, Nishimoto K, Mantero F, Rubin B, Cicala MV, Pezzani R, Auchus RJ, Ghayee HK, Shibata H, Kurihara I, Williams TA, Giri JG, Bollag RJ, Edwards MA, Isales CM, Rainey WE.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1567-72. doi: 10.1210/jc.2011-3132. Epub 2012 May 24.

2.

Development of the ISBER Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research.

Campbell LD, Betsou F, Garcia DL, Giri JG, Pitt KE, Pugh RS, Sexton KC, Skubitz AP, Somiari SB.

Biopreserv Biobank. 2012 Apr;10(2):232-3. doi: 10.1089/bio.2012.1025. No abstract available.

PMID:
24844910
3.

Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma.

Vareed SK, Bhat VB, Thompson C, Vasu VT, Fermin D, Choi H, Creighton CJ, Gayatri S, Lan L, Putluri N, Thangjam GS, Kaur P, Shabahang M, Giri JG, Nesvizhskii AI, Asea AA, Cashikar AG, Rao A, McLoughlin J, Sreekumar A.

PLoS One. 2011 Mar 23;6(3):e17177. doi: 10.1371/journal.pone.0017177.

4.

Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors.

Romero-Sánchez M, Peiper SC, Evans B, Wang Z, Catasús L, Ribe A, Prat J, Giri JG.

Hum Pathol. 2008 Jul;39(7):1026-33. doi: 10.1016/j.humpath.2007.11.007. Epub 2008 May 13.

PMID:
18479732
5.

The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist.

Abegg AL, Vickery LE, Bremer ME, Donnelly AM, Doshi PD, Evans ML, Thurman TL, Braford SR, Caparon MH, Bauer SC, Giri JG, Welply JK, McKearn JP, Smith WG.

Leukemia. 2002 Mar;16(3):316-26.

6.

Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.

Doshi PD, Giri JG, Abegg AL, Favara JP, Huynh MS, Kahn LE, Minnerly JC, Pegg LE, Villani-Price D, Siegel NR, Staten NR, Thomas JW, McKearn JP, Smith WG.

Exp Hematol. 2001 Oct;29(10):1177-84.

PMID:
11602319
8.

Synthesis and release of B-lymphocyte stimulator from myeloid cells.

Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, Sosnovtseva S, Carrell JA, Feng P, Giri JG, Hilbert DM.

Blood. 2001 Jan 1;97(1):198-204.

9.

Megakaryocyte ex vivo expansion potential of three hematopoietic sources in serum and serum-free medium.

Lefebvre P, Winter JN, Kahn LE, Giri JG, Cohen I.

J Hematother. 1999 Apr;8(2):199-208.

PMID:
10349914
10.

Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes.

Colotta F, Saccani S, Giri JG, Dower SK, Sims JE, Introna M, Mantovani A.

J Immunol. 1996 Apr 1;156(7):2534-41.

PMID:
8786316
12.

Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor.

Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM.

EMBO J. 1995 Aug 1;14(15):3654-63.

14.

IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2.

Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, Cosman D.

J Leukoc Biol. 1995 May;57(5):763-6. Review.

PMID:
7759955
15.

Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.

Giri JG, Wells J, Dower SK, McCall CE, Guzman RN, Slack J, Bird TA, Shanebeck K, Grabstein KH, Sims JE, et al.

J Immunol. 1994 Dec 15;153(12):5802-9.

PMID:
7989776
16.

Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.

Arend WP, Malyak M, Smith MF Jr, Whisenand TD, Slack JL, Sims JE, Giri JG, Dower SK.

J Immunol. 1994 Nov 15;153(10):4766-74.

PMID:
7963543
17.

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA.

J Exp Med. 1994 Oct 1;180(4):1395-403.

18.

The two interleukin-1 receptors play different roles in IL-1 actions.

Sims JE, Giri JG, Dower SK.

Clin Immunol Immunopathol. 1994 Jul;72(1):9-14. Review.

PMID:
8020198
19.

Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.

Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D.

EMBO J. 1994 Jun 15;13(12):2822-30.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk